China Bans Microbeads in Cosmetics
On 16th January 2020, China’s National Development and Reform Commission (NDRC) issued the Notice [2020] No. 80, with the aim of prohibiting the use of microbeads in cosmetics and personal care products. More detailed information was given in the Notice [2020] No. 1146, issued by the NDRC on 10th July 2020.
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate

FUTURE BAN OF THE USE OF MICROBEADS IN COSMETICS MARKETED IN CHINA 

Microbeads are defined as small pieces of plastic particles, smaller than 5 millimetres, with various shapes (e.g. spherical, polygon and are widely used in cosmetics and personal care products in China. They normally contain non-degradable polymers and are usually used in rinse-off products with the intention of scrubbing, exfoliating and cleaning.  

The major problem regarding the use of microbeads is that the release of microplastics from various products (mainly from cosmetics) affects the aquatic environment, especially marine ecosystems. Since China is one of the world’s largest cosmetics market, it results in a major effect on plastic pollution.  

In 2017, China’s former Ministry of Environmental Protection (now Ministry of Ecology and Environment), listed microbeads as products with a high pollution and high environmental risk.  

At the moment, there is no legislation or formal ban on the use microbeads in cosmetics in China, but this fact will change until the end of the year. 

China’s National Development and Reform Commission (NDRC), together with other relevant departments, organized a draft of the Catalogue of Prohibited or Restricted Production, Sale and Use of Plastic Products and published it in last April 2020, requesting public opinions. Shower gel, shampoo, conditioner, cleanser, liquid soap, soap, scrubs, toothpaste and other products were included in the list of products containing microbeads marketed in China. Microbeads that are unintentionally introduced by the product packaging and consequently do not have a specific function in such product are not included in the list. 

On 16th January 2020, China’s NDRC and the Ministry of Ecology and Environment issued the Notice [2020] No. 80 “Opinions on Further Strengthening the Control of Plastic Pollution”, with the aim of prohibiting the use of microbeads in cosmetics and personal care products. According to this Notice, the manufacturing and sale of cosmetic products containing plastic microbeads will be prohibited by the end of 2020.  

Definition, testing methods and standards for microbeads were explained in the standard for the Determination of Microbeads in Cosmetics (draft for comments), released by the State Administration for Market Regulation and China National Standardization Administration (March 2020). 

More detailed information was given in the Notice [2020] No. 1146, issued by the NDRC on 10th July 2020. The ban will apply to rinse-off products intended for scrubbing, exfoliating, and other purposes (e.g. shampoo, shower gel, scrubs, cleansers, etc.) containing intentionally added plastic particles with a size inferior to 5 millimetres. The ban also applies to toothpastes and toothpowders. 

Due to the continuous innovation in the cosmetic industry (and other industries), there are several natural and biodegradable alternatives to the use of microbeads, especially when it comes to rinse-off products. Cosmetic companies should be prepared for this ban and search the most adequate alternatives. 

References: 

  1. China National Development and Reform Commission [website] – https://www.ndrc.gov.cn/ 
  1. China National Development and Reform Commission – Consultation Notice, 10 of April 2020. Available at: https://hd.ndrc.gov.cn/yjzx/yjzx_add_wap.jsp?SiteId=332&from=singlemessage&isappinstalled=0 
  1. Draft Catalogue of plastic products prohibited and restricted from production, sale and use (Chinese). Available at: https://www.ndrc.gov.cn/yjzxDownload/jzxzsc20200410.pdf 
  1. National Development and Reform Commission and Ministry of Ecology and Environment, Notice (2020) No. 80, China. Available at: https://www.ndrc.gov.cn/xxgk/zcfb/tz/202001/t20200119_1219275.html 
  1. National Development and Reform Commission, Notice (2020) No. 1146, China. Available at: https://www.ndrc.gov.cn/xxgk/zcfb/tz/202007/t20200717_1233956.html 

further
reading

medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
parfum_fragrance_allergen_1
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »